A Pilot Study of the PI3K Inhibitor BKM120 in Patients With Relapsed Lymphoma
Phase of Trial: Phase II
Latest Information Update: 11 Oct 2018
At a glance
- Drugs Buparlisib (Primary)
- Indications B-cell lymphoma; Diffuse large B cell lymphoma; Follicular lymphoma; Mantle-cell lymphoma
- Focus Therapeutic Use
- 24 Mar 2017 Status changed from active, no longer recruiting to completed.
- 20 Dec 2016 Planned primary completion date changed from 1 Sep 2016 to 1 Sep 2017.
- 24 Jun 2015 Planned primary completion date changed from 1 Sep 2014 to 1 Sep 2016 as per ClinicalTrials.gov record.